XML 28 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Treasury Stock, At Cost
Retained (Deficit) Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balances (in shares) at Dec. 31, 2020   37,552,000        
Beginning balances at Dec. 31, 2020 $ 106.8 $ 0.4 $ 193.5 $ (24.0) $ (66.5) $ 3.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 2.9   2.9      
Issuance of restricted stock (in shares)   78,000        
Issuance of restricted stock 0.0   (1.3) 1.3    
Stock withheld for employee taxes (in shares)   (77,000)        
Stock withheld for employee taxes (3.0)     (3.0)    
Proceeds from issuance of common stock (in shares)   246,000        
Proceeds from issuance of common stock 4.9   (0.4) 5.3    
Dividends (62.3)       (62.3)  
Issuance of shares under employee stock purchase plan (in shares)   55,000        
Issuance of shares under employee stock purchase plan 1.1   1.1      
Change in cumulative translation adjustment (0.1)         (0.1)
Net income 103.3       103.3  
Ending balances (in shares) at Dec. 31, 2021   37,854,000        
Ending balances at Dec. 31, 2021 153.6 $ 0.4 195.8 (20.4) (25.5) 3.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 4.5   4.5      
Issuance of restricted stock (in shares)   32,000        
Issuance of restricted stock 0.0   (0.6) 0.6    
Stock withheld for employee taxes (in shares)   (12,000)        
Stock withheld for employee taxes (0.4)     (0.4)    
Proceeds from issuance of common stock (in shares)   34,000        
Proceeds from issuance of common stock 0.8   0.1 0.7    
Dividends (27.4)       (27.4)  
Issuance of shares under employee stock purchase plan (in shares)   53,000        
Issuance of shares under employee stock purchase plan 1.4   1.4      
Change in cumulative translation adjustment (0.9)         (0.9)
Net income $ 78.8       78.8  
Ending balances (in shares) at Dec. 31, 2022 37,960,605 37,961,000        
Ending balances at Dec. 31, 2022 $ 210.4 $ 0.4 201.2 (19.5) 25.9 2.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 3.0   3.0      
Issuance of restricted stock (in shares)   44,000        
Issuance of restricted stock 0.0   (0.7) 0.7    
Stock withheld for employee taxes (in shares)   (19,000)        
Stock withheld for employee taxes (0.5)   (0.2) (0.3)    
Proceeds from issuance of common stock (in shares)   29,000        
Proceeds from issuance of common stock 0.6   0.1 0.5    
Dividends (30.6)       (30.6)  
Issuance of shares under employee stock purchase plan (in shares)   59,000        
Issuance of shares under employee stock purchase plan 1.4   1.4      
Change in cumulative translation adjustment 0.2         0.2
Net income $ 70.7       70.7  
Ending balances (in shares) at Dec. 31, 2023 38,074,344 38,074,000        
Ending balances at Dec. 31, 2023 $ 255.2 $ 0.4 $ 204.8 $ (18.6) $ 66.0 $ 2.6